Dolby Laboratories Reports Mixed Q3 Earnings, Sends Shares Higher
On July 31, Dolby Laboratories (NYSE: DLB) saw its stock rise by over 11% after reporting mixed financial results for fiscal Q3 2026. The company beat earnings estimates with $0.69 per share on a non-GAAP basis but missed revenue forecasts at $305 million versus the expected $312 million. Year-over-year sales declined only slightly by 3.5%, and Dolby provided optimistic guidance for Q4, forecasting sequential growth of up to 19% with revenues between $362 million and $392 million. Despite these positive signals, GAAP earnings were significantly lower at just $0.30 per share—a drop of 37% year-over-year—highlighting the importance of non-GAAP adjustments in interpreting performance. CEO Kevin Yeaman expressed confidence in Dolby's momentum across key growth areas and full-year objectives. The stock’s sharp rise reflects investor optimism, though some analysts caution that a forward P/E ratio of around 21.5 may be high for a company with modest sales and earnings growth.
Tickers: $DLB